Charles Dasher
Gastroenterology · Homewood, ALNPI 1851552111
Payments from drug & device makers
Across 384 payments — averaging $1735.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Genentech, Inc.$540K
- Bausch Health US, LLC$55K
- Braintree Laboratories, Inc.$21K
- Amgen$21K
- Chugai Pharmaceutical Co., Ltd.$15K
- Eli Lilly$8K
- plus $6K from 21 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Genentech, Inc. | 44 | $539,936 |
| Bausch Health US, LLC | 32 | $54,535 |
| Braintree Laboratories, Inc. | 4 | $21,161 |
| Amgen | 8 | $20,987 |
| Chugai Pharmaceutical Co., Ltd. | 2 | $14,954 |
| Eli Lilly | 2 | $8,350 |
| Johnson & Johnson | 62 | $1,397 |
| AbbVie(2 entities) | 73 | $1,395 |
| Bristol Myers Squibb | 29 | $540 |
| Pfizer | 27 | $523 |
| Ardelyx, Inc. | 20 | $411 |
| Takeda Pharmaceuticals U.S.A., Inc. | 20 | $319 |
| Madrigal Pharmaceuticals | 10 | $312 |
| Lilly USA, LLC | 8 | $213 |
| Phathom Pharmaceuticals, Inc. | 8 | $210 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 12 | $198 |
| Gilead | 4 | $171 |
| E.r. Squibb & Sons, L.L.C. | 1 | $114 |
| Romark Laboratories, LC | 1 | $109 |
| Redhill Biopharma Inc. | 1 | $109 |
| Sanofi | 5 | $91 |
| Boston Scientific | 3 | $81 |
| Celltrion USA Inc. | 3 | $60 |
| Ironwood Pharmaceuticals, Inc | 2 | $32 |
| Enterra Medical, Inc. | 1 | $30 |
| Organon | 1 | $24 |
| Aimmune Therapeutics, Inc. | 1 | $18 |
How this compares
$666,279 in reported general payments places this provider in the 95th percentile of 225 gastroenterology providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other gastroenterology in Homewood
- Jonathan SiegelMobile$2.6M
- Michael BrownDecatur$1.7M
- Paul LambDothan$1.2M
- Robert ShafferBirmingham$1.2M
- Charles JohnsonMobile$1.2M
- Jack DipalmaMobile$958K
- William McLaughlinDothan$745K
- Samuel TarwaterDothan$664K
- Meagan GrayBirmingham$600K
- Travis RutlandDothan$552K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.